bluuebunny/crossref_metadata_2025 huggingface dataset:
Approval notice from Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas
Authors: Zhu Haibo , Guo Jing , Shen Yutao , Dong Wei , Gao Hua , Miao Yazhou , Li Chuzhong , Zhang Yazhuo
Published: April 2023

IRB of Beijing Tiantan Hospital Affiliated to Medical University
Supplementary Data from Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma
Authors: Duan Meng , Goswami Shyamal , Shi Jie-Yi , Wu Lin-Jie , Wang Xiao-Ying , Ma Jia-Qiang , Zhang Zhao , Shi Yang , Ma Li-Jie , Zhang Shu , Xi Rui-Bin , Cao Ya , Zhou Jian , Fan Jia , Zhang Xiao-Ming , Gao Qiang
Published: April 2023

Supplementary Table S1
Supplementary Table S4. from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma
Authors: Damayanti Nur P. , Budka Justin A. , Khella Heba W.Z , Ferris Mary W. , Ku Sheng Yu , Kauffman Eric , Wood Anthony C. , Ahmed Khunsha , Chintala Venkata Nithinsai , Adelaiye-Ogala Remi , Elbanna May , Orillion Ashley , Chintala Sreenivasulu , Kao Chinghai , Linehan W. Marston , Yousef George M. , Hollenhorst Peter C. , Pili Roberto
Published: April 2023

Comprehensive panels of 96 PANTHER pathways identified by bioinformatics analysis of TFE3 ChIP-seq peaks in RP-R07 cells.
Supplementary Table S1 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma
Authors: Damayanti Nur P. , Budka Justin A. , Khella Heba W.Z , Ferris Mary W. , Ku Sheng Yu , Kauffman Eric , Wood Anthony C. , Ahmed Khunsha , Chintala Venkata Nithinsai , Adelaiye-Ogala Remi , Elbanna May , Orillion Ashley , Chintala Sreenivasulu , Kao Chinghai , Linehan W. Marston , Yousef George M. , Hollenhorst Peter C. , Pili Roberto
Published: April 2023

Quality control for ChIP-seq
Supplementary Figure S3 from Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib
Authors: Rini Brian I. , Escudier Bernard , Martini Jean-Francois , Magheli Ahmed , Svedman Christer , Lopatin Margarita , Knezevic Dejan , Goddard Audrey D. , Febbo Phillip G. , Li Rachel , Lin Xun , Valota Olga , Staehler Michael , Motzer Robert J. , Ravaud Alain
Published: April 2023

Kaplan-Meier estimates for RCSS by RS risk group in (A) placebo arm and (B) sunitinib arm. *Log-rank test for high vs low RS risk groups. â€ No events observed by 5 years. Abbreviations: CI, confidence interval; RCCS, renal cancer-specific survival; RS, recurrence score.
Supplementary Figure 3 from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity
Authors: Boysen Gunther , Rodrigues Daniel N. , Rescigno Pasquale , Seed George , Dolling David , Riisnaes Ruth , Crespo Mateus , Zafeiriou Zafeiris , Sumanasuriya Semini , Bianchini Diletta , Hunt Joanne , Moloney Deirdre , Perez-Lopez Raquel , Tunariu Nina , Miranda Susana , Figueiredo Inês , Ferreira Ana , Christova Rossitza , Gil Veronica , Aziz Sara , Bertan Claudia , de Oliveira Flavia M. , Atkin Mark , Clarke Matthew , Goodall Jane , Sharp Adam , MacDonald Theresa , Rubin Mark A. , Yuan Wei , Barbieri Christopher E. , Carreira Suzanne , Mateo Joaquin , de Bono Johann S.
Published: April 2023

Combined SPOP/ CHD1 status and time/ response to abiraterone.
Supplementary Figure 2 from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity
Authors: Boysen Gunther , Rodrigues Daniel N. , Rescigno Pasquale , Seed George , Dolling David , Riisnaes Ruth , Crespo Mateus , Zafeiriou Zafeiris , Sumanasuriya Semini , Bianchini Diletta , Hunt Joanne , Moloney Deirdre , Perez-Lopez Raquel , Tunariu Nina , Miranda Susana , Figueiredo Inês , Ferreira Ana , Christova Rossitza , Gil Veronica , Aziz Sara , Bertan Claudia , de Oliveira Flavia M. , Atkin Mark , Clarke Matthew , Goodall Jane , Sharp Adam , MacDonald Theresa , Rubin Mark A. , Yuan Wei , Barbieri Christopher E. , Carreira Suzanne , Mateo Joaquin , de Bono Johann S.
Published: April 2023

Additional Information on molecular analyses determining CHD1 and SPOP status
Supplementary Figures from Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma
Authors: Pang Ying , Lu Yanxin , Caisova Veronika , Liu Yang , Bullova Petra , Huynh Thanh-Truc , Zhou Yiqiang , Yu Di , Frysak Zdenek , Hartmann Igor , Taïeb David , Pacak Karel , Yang Chunzhang
Published: April 2023

Supplementary Figures S1 A. Quantitative PCR showed CA9, PNMT, and VEGFA expression in MTT cells. Higher expressions of hypoxia related genes were detected in SDHBKD cells. B. NAD+ quantification confirmed depletion of NAD+ by Nampt inhibitors FK866 and CHS828. C. Blue native gel analysis on mitochondrial complex formation in MTT cells (left panel). Mitochondrial complex I formation is increased in SDHBKD cells. In gel enzyme activity assay (IGA) showed elevated mitochondrial complex I activity in SDHBKD cells (right panel). D. Re-expression of SDHB in MTT cells (upper panel). The re-expression of SDHB reduced pADPR formation in SDHBKD cells, with a corresponding increased of Î³H2A.X expression (lower panel). E. Quantification of NAD+/NADH ratio in MTT cells. Re-expression of SDHB partially reversed the elevated NAD+/NADH ratio in SDHBKD cells. F. Quantification of flow cytometry data. A significant G2/M arrest is seen in combination treated group. G. Western blot for MGMT detection in MTT cells. No MGMT expression was seen in either SDHBWT or SDHBKD cells.ï€ ï�¢-actin was used as loading control. H. Cell viability test showing enhanced cytotoxic effect of combination treatment. **p<0.01. I. In vivo bioluminescence showing significantly reduced metastatic lesion with TMZ and combination treatments. *p<0.05, **p<0.01.
Figure S5 from SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy
Authors: Wang Feng , Xia Xiaojun , Yang Chunying , Shen Jianliang , Mai Junhua , Kim Han-Cheon , Kirui Dickson , Kang Ya'an , Fleming Jason B. , Koay Eugene J. , Mitra Sankar , Ferrari Mauro , Shen Haifa
Published: April 2023

Figure S5. SMAD4-induced autophagy is partially rescued by ROS scavenger. (A) Panc-1 cells with Smad4 knockdown were treated with NAC, irradiation (IR), or NAC plus IR. Cell lysates were harvested and blotted with different antibodies indicated. (B) Panc-1 cells with Smad4 knockdown were treated with medium (Control), NAC, or CQ. Cell lysates were harvested and blotted with different antibodies as indicated.
Figure S4 from SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy
Authors: Wang Feng , Xia Xiaojun , Yang Chunying , Shen Jianliang , Mai Junhua , Kim Han-Cheon , Kirui Dickson , Kang Ya'an , Fleming Jason B. , Koay Eugene J. , Mitra Sankar , Ferrari Mauro , Shen Haifa
Published: April 2023

Figure S4. SMAD4-induced IR-resistance is partially rescued by pretreatment of autophagy inhibitor or ROS scavenger. (A) Immunoblot of SMAD4 was measured using antibody against SMAD4 in Panc-1-CTL, Panc-1-sh-SMAD4-#2 Cells. (B-C) Panc-1-CTL, Panc-1-sh-SMAD4-#2 Cells were pretreated with 10μM chloroquine (CQ) (B) or 3mM N-acetyl-L-cysteine (NAC) (C) for 1 h, and then treated with indicated doses of IR and colony formation assays were conducted with more than 50 cells counted. Shown are the averages of triplicate samples. Standard errors are shown by error bars. * , P < .05, **, P < .001
Supplementary Figure 7 from A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models
Authors: Zinn Pascal O. , Singh Sanjay K. , Kotrotsou Aikaterini , Hassan Islam , Thomas Ginu , Luedi Markus M. , Elakkad Ahmed , Elshafeey Nabil , Idris Tagwa , Mosley Jennifer , Gumin Joy , Fuller Gregory N. , de Groot John F. , Baladandayuthapani Veera , Sulman Erik P. , Kumar Ashok J. , Sawaya Raymond , Lang Frederick F. , Piwnica-Worms David , Colen Rivka R.
Published: April 2023

Supplementary Figure 7
Figure S1 from SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy
Authors: Wang Feng , Xia Xiaojun , Yang Chunying , Shen Jianliang , Mai Junhua , Kim Han-Cheon , Kirui Dickson , Kang Ya'an , Fleming Jason B. , Koay Eugene J. , Mitra Sankar , Ferrari Mauro , Shen Haifa
Published: April 2023

Figure S1. SMAD4 depletion impaired DNA Double-Strand Break Signaling in response to ionizing radiation in Panc-1 cells using shRNA lentiviral vector. Panc-1 cells were transfected with a control shRNA lentiviral vector or shRNA lentiviral vector against SMAD4 and selected clone Panc-1-shSMAD4-#2, and then exposed to γ-irradiation (6 Gy) or mock treatment. Total cell lysates were harvested followed by immunoblotting with the indicated antibodies.
supplementary tables from Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma
Authors: van IJzendoorn David G.P. , Sleijfer Stefan , Gelderblom Hans , Eskens Ferry A.L.M. , van Leenders Geert J.L.H. , Szuhai Karoly , Bovée Judith V.M.G.
Published: April 2023

Supplementary table 1 Primers sequences used for Real-Time qPCR. Supplementary table 2 ShRNA used for inhibition of the receptors, for each receptor the most effective shRNA was selected as tested with Real-Time qPCR. Supplementary table 3 Sequence of the primers used for ChIP-qPCR.
legends supplementary figures from Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma
Authors: van IJzendoorn David G.P. , Sleijfer Stefan , Gelderblom Hans , Eskens Ferry A.L.M. , van Leenders Geert J.L.H. , Szuhai Karoly , Bovée Judith V.M.G.
Published: April 2023

legends supplementary figures 1-4
Sup Fig 1 and 2 from STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder Cancer
Authors: Lelo Alana , Prip Frederik , Harris Brent T. , Solomon David , Berry Deborah L. , Chaldekas Krysta , Kumar Anagha , Simko Jeffry , Jensen Jørgen Bjerggaard , Bhattacharyya Pritish , Mannion Ciaran , Kim Jung-Sik , Philips George , Dyrskjøt Lars , Waldman Todd
Published: April 2023

Supplemental Figure 1. Georgetown cohort Supplemental Figure 2. Aarhus cohort
Table S3 from Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer
Authors: Bonazzoli Elena , Predolini Federica , Cocco Emiliano , Bellone Stefania , Altwerger Gary , Menderes Gulden , Zammataro Luca , Bianchi Anna , Pettinella Francesca , Riccio Francesco , Han Chanhee , Yadav Ghanshyam , Lopez Salvatore , Manzano Aranzazu , Manara Paola , Buza Natalia , Hui Pei , Wong Serena , Litkouhi Babak , Ratner Elena , Silasi Dan-Arin , Huang Gloria S. , Azodi Masoud , Schwartz Peter E. , Schlessinger Joseph , Santin Alessandro D.
Published: April 2023

Groups and dosing description of the in vivo drug study on USC-ARK1 xenograft.
Supplementary data from Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms
Authors: El Charif Omar , Mapes Brandon , Trendowski Matthew R. , Wheeler Heather E. , Wing Claudia , Dinh Paul C. , Frisina Robert D. , Feldman Darren R. , Hamilton Robert J. , Vaughn David J. , Fung Chunkit , Kollmannsberger Christian , Mushiroda Taisei , Kubo Michiaki , Gamazon Eric R. , Cox Nancy J. , Huddart Robert , Ardeshir-Rouhani-Fard Shirin , Monahan Patrick , Fossa Sophie D. , Einhorn Lawrence H. , Travis Lois B. , Dolan M. Eileen
Published: April 2023

Supplementary data from Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms
Supplementary Table 1 from Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival
Authors: Antonarakis Emmanuel S. , Small Eric J. , Petrylak Daniel P. , Quinn David I. , Kibel Adam S. , Chang Nancy N. , Dearstyne Erica , Harmon Matt , Campogan Dwayne , Haynes Heather , Vu Tuyen , Sheikh Nadeem A. , Drake Charles G.
Published: April 2023

Baseline characteristics of patients in STAMP and STRIDE trials stratified by lower, middle, and upper tertiles of CTL activity
Supplementary Table S2: Summary of bioinformatics based studies of B cell and plasma cell gene signatures from Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
Authors: Wouters Maartje C.A. , Nelson Brad H.
Published: April 2023

Summary of bioinformatics based studies of B cell and plasma cell gene signatures
Supplementary Table S1: Parameter used for analysis when multiple parameters were reported from Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
Authors: Wouters Maartje C.A. , Nelson Brad H.
Published: April 2023

Parameter used for analysis when multiple parameters were reported
Supplementary Material from KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case–Control Study
Authors: Scelo Ghislaine , Muller David C. , Riboli Elio , Johansson Mattias , Cross Amanda J. , Vineis Paolo , Tsilidis Konstantinos K. , Brennan Paul , Boeing Heiner , Peeters Petra H.M. , Vermeulen Roel C.H. , Overvad Kim , Bueno-de-Mesquita H. Bas , Severi Gianluca , Perduca Vittorio , Kvaskoff Marina , Trichopoulou Antonia , La Vecchia Carlo , Karakatsani Anna , Palli Domenico , Sieri Sabina , Panico Salvatore , Weiderpass Elisabete , Sandanger Torkjel M. , Nøst Therese H. , Agudo Antonio , Quirós J. Ramón , Rodríguez-Barranco Miguel , Chirlaque Maria-Dolores , Key Timothy J. , Khanna Prateek , Bonventre Joseph V. , Sabbisetti Venkata S. , Bhatt Rupal S.
Published: April 2023

Supplementary Table 1, Supplementary Figures 1 and 2
Supplementary Figures from A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
Authors: Bendell Johanna C. , Varghese Anna M. , Hyman David M. , Bauer Todd M. , Pant Shubham , Callies Sophie , Lin Ji , Martinez Ricardo , Wickremsinhe Enaksha , Fink Aaron , Wacheck Volker , Moore Kathleen N.
Published: April 2023

Figures S1 to S4
Bendell et al_Supplementary Figures from A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
Authors: Bendell Johanna C. , Varghese Anna M. , Hyman David M. , Bauer Todd M. , Pant Shubham , Callies Sophie , Lin Ji , Martinez Ricardo , Wickremsinhe Enaksha , Fink Aaron , Wacheck Volker , Moore Kathleen N.
Published: April 2023

Supplemental Figures: S1-S4
Table S1 from Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts
Authors: Kim Kwanghee , Watson Philip A. , Lebdai Souhil , Jebiwott Sylvia , Somma Alexander J. , La Rosa Stephen , Mehta Dipti , Murray Katie S. , Lilja Hans , Ulmert David , Monette Sebastien , Scherz Avigdor , Coleman Jonathan A.
Published: April 2023

HALLMARK gene set
Figure S1 from False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Authors: Hu Yuebi , Ulrich Bryan C. , Supplee Julianna , Kuang Yanan , Lizotte Patrick H. , Feeney Nora B. , Guibert Nicolas M. , Awad Mark M. , Wong Kwok-Kin , Jänne Pasi A. , Paweletz Cloud P. , Oxnard Geoffrey R.
Published: April 2023

Droplet digital PCR (ddPCR) detected the KRAS mutation in peripheral blood cells (PBC, A) but did not detect the EGFR driver mutation (B). Highly sensitive next-generation sequencing (NGS, C) confirmed the presence of the KRAS G12D mutation in PBC and cellular subpopulations (D) at a similar allelic fraction (AF) as found with ddPCR.
Supplemental Table 2 from Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Authors: Subbiah Vivek , Lamhamedi-Cherradi Salah-Eddine , Cuglievan Branko , Menegaz Brian A. , Camacho Pamela , Huh Winston , Ramamoorthy Vandhana , Anderson Pete M. , Pollock Raphael E. , Lev Dina C. , Qiao Wei , McAleer Mary Frances , Benjamin Robert S. , Patel Shreyaskumar , Herzog Cynthia E. , Daw Najat C. , Feig Barry W. , Lazar Alexander J. , Hayes-Jordan Andrea , Ludwig Joseph A.
Published: April 2023

Multivariate parameters for all patients with OS from date of diagnosis, WART effect for CCS surgery patients with OS starting from surgery time, and statistics
Supplementary Methods from Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma
Authors: Kesarwani Pravin , Prabhu Antony , Kant Shiva , Kumar Praveen , Graham Stewart F. , Buelow Katie L. , Wilson George D. , Miller C. Ryan , Chinnaiyan Prakash
Published: April 2023

Supplementary Methods with description on Microarray analysis, Tumor models, Kynurenine estimation, Western Blotting, LC-MS and Flow cytometry.
Supplementary Table S2 from High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients
Authors: Chen Justin , Haanpää Maria K. , Gruber Joshua J. , Jäger Natalie , Ford James M. , Snyder Michael P.
Published: April 2023

List of regions identified as having potential allelic methylation
Supplementary Figure S2 from High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients
Authors: Chen Justin , Haanpää Maria K. , Gruber Joshua J. , Jäger Natalie , Ford James M. , Snyder Michael P.
Published: April 2023

Figure S2. Bisulfite sequencing after target enrichment provides highly quantitative methylation data across the genome. A) Average read depth for all samples was 71X, with an estimated bisulfite conversion rate of 98.69% across all samples. B) Increased read depth per CpG provides greater quantitative reliability; we routinely observed over 3 million CpGs with at least 5 reads. C) Kernel density plots of each subgroup within the cohort (Affect Carriers, Affected Noncarriers, Healthy Controls, and Unaffected Carriers) showed little global variation. D) Principle Component Analysis of the most variant CpGs across the cohort (n=7,590) did not separate sample subgroups and was only able to capture 5.615% and 1.677% of the variance in principle components 1 and 2, respectively.
Supplementary Information from Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2
Authors: Cazzamalli Samuele , Ziffels Barbara , Widmayer Fontaine , Murer Patrizia , Pellegrini Giovanni , Pretto Francesca , Wulhfard Sarah , Neri Dario
Published: April 2023

Detailed synthetic procedures, chemical and biological characterization of relevant compounds
Figure S2 from Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile
Authors: Xie Nan , Matigian Nicholas , Vithanage Tharindu , Gregory Kye , Nassar Zeyad D. , Cabot Peter J. , Shaw Paul N. , Kirkpatrick Carl M.J. , Cao Kim-Anh Lê , Sturgess David , Parat Marie-Odile
Published: April 2023

Correlation of cAMP production and LPS-induced TLR4 activation in morphine-treated mice. Mice were treated with saline or morphine (1 or 10 mg/kg) and plasma samples were collected 10 min after intraperitoneal injection. Production of cAMP by HEK-MOP cells was determined using the AlphascreenTM assay. HEK-Blue{trade mark, serif} hTLR4 cells were treated with 1 ng/mL LPS and 5% (v/v) mouse plasma, and the levels of SEAP were determined using QUANTI-Blue{trade mark, serif}. Scatter plot shows LPS-induced TLR4 activation and cAMP production for n=18 mice. Pair-wise correlation was assessed using the Pearson's method with GraphPad Prism software (v. 7.00).
Figure S2 from Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Authors: Kelly Kevin R. , Friedberg Jonathan W. , Park Steven I. , McDonagh Kevin , Hayslip John , Persky Daniel , Ruan Jia , Puvvada Soham , Rosen Peter , Iyer Swaminathan Padmanabhan , Stefanovic Alexandra , Bernstein Steven H. , Weitman Steven , Karnad Anand , Monohan Gregory , VanderWalde Ari , Mena Raul , Schmelz Monika , Spier Catherine , Groshen Susan , Venkatakrishnan Karthik , Zhou Xiaofei , Sheldon-Waniga Emily , Leonard E. Jane , Mahadevan Daruka
Published: April 2023

Immunohistochemical staining of Bcl2, cMyc, Ki67, and CD3 in DLBCL subtype representative tumor samples (same as Supplementary Figure S1). Note that AD091967 is positive for both Bcl2 and cMyc. Cases AB189717, AD550620, and AE575816 show high proliferation rates (80%, 80%, 60%) Scale bars represent 50 µm.
Figure S1 from Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Authors: Kelly Kevin R. , Friedberg Jonathan W. , Park Steven I. , McDonagh Kevin , Hayslip John , Persky Daniel , Ruan Jia , Puvvada Soham , Rosen Peter , Iyer Swaminathan Padmanabhan , Stefanovic Alexandra , Bernstein Steven H. , Weitman Steven , Karnad Anand , Monohan Gregory , VanderWalde Ari , Mena Raul , Schmelz Monika , Spier Catherine , Groshen Susan , Venkatakrishnan Karthik , Zhou Xiaofei , Sheldon-Waniga Emily , Leonard E. Jane , Mahadevan Daruka
Published: April 2023

Hematoxylin and eosin (H&E), CD20, CD10, Bcl6, and MUM1 stainings in 4 non-GCB and 2 GCB cases representative for each DLBCL subtype. Bars, 50 µm.
Table S3 from Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Authors: Soumerai Tara E. , Donoghue Mark T.A. , Bandlamudi Chaitanya , Srinivasan Preethi , Chang Matthew T. , Zamarin Dmitriy , Cadoo Karen A. , Grisham Rachel N. , O'Cearbhaill Roisin E. , Tew William P. , Konner Jason A. , Hensley Martee L. , Makker Vicky , Sabbatini Paul , Spriggs David R. , Troso-Sandoval Tiffany A. , Charen Alexandra Snyder , Friedman Claire , Gorsky Mila , Schweber Sarah J. , Middha Sumit , Murali Rajmohan , Chiang Sarah , Park Kay J. , Soslow Robert A. , Ladanyi Marc , Li Bob T. , Mueller Jennifer , Weigelt Britta , Zehir Ahmet , Berger Michael F. , Abu-Rustum Nadeem R. , Aghajanian Carol , DeLair Deborah F. , Solit David B. , Taylor Barry S. , Hyman David M.
Published: April 2023

Clinical and genetic characteristics of somatic copy number alteration clusters
Table S1 from Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Authors: Soumerai Tara E. , Donoghue Mark T.A. , Bandlamudi Chaitanya , Srinivasan Preethi , Chang Matthew T. , Zamarin Dmitriy , Cadoo Karen A. , Grisham Rachel N. , O'Cearbhaill Roisin E. , Tew William P. , Konner Jason A. , Hensley Martee L. , Makker Vicky , Sabbatini Paul , Spriggs David R. , Troso-Sandoval Tiffany A. , Charen Alexandra Snyder , Friedman Claire , Gorsky Mila , Schweber Sarah J. , Middha Sumit , Murali Rajmohan , Chiang Sarah , Park Kay J. , Soslow Robert A. , Ladanyi Marc , Li Bob T. , Mueller Jennifer , Weigelt Britta , Zehir Ahmet , Berger Michael F. , Abu-Rustum Nadeem R. , Aghajanian Carol , DeLair Deborah F. , Solit David B. , Taylor Barry S. , Hyman David M.
Published: April 2023

Additional clinical information for patients in MSKCC cohort
Figure S2 from The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy
Authors: Yordanova Anna , Wicharz Marcel M. , Mayer Karin , Brossart Peter , Gonzalez-Carmona Maria A. , Strassburg Christian P. , Fimmers Rolf , Essler Markus , Ahmadzadehfar Hojjat
Published: April 2023

Incidence of treated patients in both groups between 2004 and 2016. This graph shows that there was no significant change in the treatment protocol (PRRT monotherapy/ or combination therapy PRRT + SSA and / or maintenance therapy with SSA) over the years at our department.
Figure S4 from Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Authors: Soumerai Tara E. , Donoghue Mark T.A. , Bandlamudi Chaitanya , Srinivasan Preethi , Chang Matthew T. , Zamarin Dmitriy , Cadoo Karen A. , Grisham Rachel N. , O'Cearbhaill Roisin E. , Tew William P. , Konner Jason A. , Hensley Martee L. , Makker Vicky , Sabbatini Paul , Spriggs David R. , Troso-Sandoval Tiffany A. , Charen Alexandra Snyder , Friedman Claire , Gorsky Mila , Schweber Sarah J. , Middha Sumit , Murali Rajmohan , Chiang Sarah , Park Kay J. , Soslow Robert A. , Ladanyi Marc , Li Bob T. , Mueller Jennifer , Weigelt Britta , Zehir Ahmet , Berger Michael F. , Abu-Rustum Nadeem R. , Aghajanian Carol , DeLair Deborah F. , Solit David B. , Taylor Barry S. , Hyman David M.
Published: April 2023

Reanalysis of TCGA high copy number burden cluster four. A. Ploidy and purity corrected clustering of SCNAs. B. Comparison of PFS between the two clusters identified in S4A.
Supplementary Figure S2 from p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial
Authors: Sperinde Jeff , Huang Weidong , Vehtari Aki , Chenna Ahmed , Kellokumpu-Lehtinen Pirkko-Liisa , Winslow John , Bono Petri , Lie Yolanda S. , Petropoulos Christos J. , Weidler Jodi , Joensuu Heikki
Published: April 2023

Supplementary Figure 2
Figure S1 from Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Authors: Soumerai Tara E. , Donoghue Mark T.A. , Bandlamudi Chaitanya , Srinivasan Preethi , Chang Matthew T. , Zamarin Dmitriy , Cadoo Karen A. , Grisham Rachel N. , O'Cearbhaill Roisin E. , Tew William P. , Konner Jason A. , Hensley Martee L. , Makker Vicky , Sabbatini Paul , Spriggs David R. , Troso-Sandoval Tiffany A. , Charen Alexandra Snyder , Friedman Claire , Gorsky Mila , Schweber Sarah J. , Middha Sumit , Murali Rajmohan , Chiang Sarah , Park Kay J. , Soslow Robert A. , Ladanyi Marc , Li Bob T. , Mueller Jennifer , Weigelt Britta , Zehir Ahmet , Berger Michael F. , Abu-Rustum Nadeem R. , Aghajanian Carol , DeLair Deborah F. , Solit David B. , Taylor Barry S. , Hyman David M.
Published: April 2023

Progression-free survival and hazard ratios by histology
Table S1 from Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
Authors: Liu Qiuli , Tong Dali , Liu Gaolei , Gao Jie , Wang Lin-ang , Xu Jing , Yang Xingxia , Xie Qiubo , Huang Yiqiang , Pang Jian , Wang Luofu , He Yong , Zhang Dianzheng , Ma Qiang , Lan Weihua , Jiang Jun
Published: April 2023

Supplementary Table S1. The clinical information of the patients.
Table S6 from A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
Authors: Tamborero David , Rubio-Perez Carlota , Muiños Ferran , Sabarinathan Radhakrishnan , Piulats Josep M. , Muntasell Aura , Dienstmann Rodrigo , Lopez-Bigas Nuria , Gonzalez-Perez Abel
Published: April 2023

Association of somatic driver alterations with immune populations
Figure S2 from Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
Authors: Liu Qiuli , Tong Dali , Liu Gaolei , Gao Jie , Wang Lin-ang , Xu Jing , Yang Xingxia , Xie Qiubo , Huang Yiqiang , Pang Jian , Wang Luofu , He Yong , Zhang Dianzheng , Ma Qiang , Lan Weihua , Jiang Jun
Published: April 2023

Supplementary Figure S2. The effects of metformin on prostate stroma cells. (A) The ratio of epithelial cells to stroma cells in the mice at week 12, 25 and 37. (B) WPMY-1 cells were seeded in 96-well plates with 0.5Ã-105 cells per well in growth media with or without metformin (20mM). Cell viabilities were estimated by CCK8 every other day. (C and D) WPMY-1 cells were treated with different concentrations of metformin and the numbers of cells at different stages of the cycle were analyzed by ï¬,ow cytometry (C), or stained with PI and FITC-labelled Annexin V and subsequently underwent ï¬,ow cytometry analysis to determine the percentage of apoptotic cells (D).
Table S1 from A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
Authors: Tamborero David , Rubio-Perez Carlota , Muiños Ferran , Sabarinathan Radhakrishnan , Piulats Josep M. , Muntasell Aura , Dienstmann Rodrigo , Lopez-Bigas Nuria , Gonzalez-Perez Abel
Published: April 2023

Gene sets representing immune cell populations and cell pathways
Figure S1 from Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
Authors: Liu Qiuli , Tong Dali , Liu Gaolei , Gao Jie , Wang Lin-ang , Xu Jing , Yang Xingxia , Xie Qiubo , Huang Yiqiang , Pang Jian , Wang Luofu , He Yong , Zhang Dianzheng , Ma Qiang , Lan Weihua , Jiang Jun
Published: April 2023

Supplementary Figure S1. The effect of metformin on the expression of KI67, AR and neuroendocrine markers (Syn and CD56). Prostate tissues from TRAMP mice in both Control (Con) and Metformin (MET) groups at week 12, 25 and 37 were stained for KI67 (A, Magnifications: 40Ã-), AR (B, Magnifications: 20Ã-) as well as Syn and CD56 (C, Magnifications: 4Ã- for the images and 40Ã- at the lower right corner). * p < 0.05.
Supplementary Table S3 from Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
Authors: Wei Jun S. , Kuznetsov Igor B. , Zhang Shile , Song Young K. , Asgharzadeh Shahab , Sindiri Sivasish , Wen Xinyu , Patidar Rajesh , Najaraj Sushma , Walton Ashley , Auvil Jaime M. Guidry , Gerhard Daniela S. , Yuksel Aysen , Catchpoole Daniel , Hewitt Stephen M. , Sondel Paul M. , Seeger Robert , Maris John M. , Khan Javed
Published: April 2023

Supplementary Table S3
Supplementary Table S2 from Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
Authors: Wei Jun S. , Kuznetsov Igor B. , Zhang Shile , Song Young K. , Asgharzadeh Shahab , Sindiri Sivasish , Wen Xinyu , Patidar Rajesh , Najaraj Sushma , Walton Ashley , Auvil Jaime M. Guidry , Gerhard Daniela S. , Yuksel Aysen , Catchpoole Daniel , Hewitt Stephen M. , Sondel Paul M. , Seeger Robert , Maris John M. , Khan Javed
Published: April 2023

Supplementary Table S2
Supplementary Table S1 from Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
Authors: Wei Jun S. , Kuznetsov Igor B. , Zhang Shile , Song Young K. , Asgharzadeh Shahab , Sindiri Sivasish , Wen Xinyu , Patidar Rajesh , Najaraj Sushma , Walton Ashley , Auvil Jaime M. Guidry , Gerhard Daniela S. , Yuksel Aysen , Catchpoole Daniel , Hewitt Stephen M. , Sondel Paul M. , Seeger Robert , Maris John M. , Khan Javed
Published: April 2023

Supplementary Table S1
Supplementary Legend from Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non–Small Cell Lung Cancer
Authors: Yu Hao , Wu Huanmei , Wang Weili , Jolly Shruti , Jin Jian-Yue , Hu Chen , Kong Feng-Ming (Spring)
Published: April 2023

Supplementary Legend
Supplementary Figure Legend from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas
Authors: Thompson John A. , Motzer Robert J. , Molina Ana M. , Choueiri Toni K. , Heath Elisabeth I. , Redman Bruce G. , Sangha Randeep S. , Ernst D. Scott , Pili Roberto , Kim Stella K. , Reyno Leonard , Wiseman Aya , Trave Fabio , Anand Banmeet , Morrison Karen , Doñate Fernando , Kollmannsberger Christian K.
Published: April 2023

Supplementary Figure Legend
Supplementary Data, Methods, Table and Figure legends from High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling
Authors: Hayashi Takuji , Fujita Kazutoshi , Nojima Satoshi , Hayashi Yujiro , Nakano Kosuke , Ishizuya Yu , Wang Cong , Yamamoto Yoshiyuki , Kinouchi Toshiro , Matsuzaki Kyosuke , Jingushi Kentaro , Kato Taigo , Kawashima Atsunari , Nagahara Akira , Ujike Takeshi , Uemura Motohide , Pena Maria Del Carmen Rodriguez , Gordetsky Jennifer B. , Morii Eiichi , Tsujikawa Kazutake , Netto George J. , Nonomura Norio
Published: April 2023

Detailed data were described.
Table S1 from Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
Authors: Cai Zhixiong , Chen Geng , Zeng Yongyi , Dong Xiuqing , Li Zhenli , Huang Yanbing , Xin Fuli , Qiu Liman , Xu Haipo , Zhang Wei , Su Xiaoping , Liu Xiaolong , Liu Jingfeng
Published: April 2023

Clinical characteristics of 34 enrolled HCC patients.
Supplementary Tables from Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma
Authors: Peng Hao , Dong Di , Fang Meng-Jie , Li Lu , Tang Ling-Long , Chen Lei , Li Wen-Fei , Mao Yan-Ping , Fan Wei , Liu Li-Zhi , Tian Li , Lin Ai-Hua , Sun Ying , Tian Jie , Ma Jun
Published: April 2023

Table S1. Numbers of features remained after each selection step for CT-based signature building. Table S2. Numbers of features remained after each selection step for PET-based signature building. Table S3. Results of radiomics feature selection and Rad-score building. Table S4. Comparison of signatures combining features of different categories. Table S5. Results of univariate analysis. Table S6. Multivariate analysis results for disease-free survival in training set. Table S7. Baseline information of nomogram-defined high-risk and low-risk groups. Table S8. Survival outcomes between radiomics nomogram-defined high and low risk groups. Table S9. Results of multivariate analysis for the whole cohort. Table S10. Results of multivariate analysis within the high-risk group. Table S11. Results of multivariate analysis within the low-risk group. Table S12. Results of multivariate analysis within the low-risk group defined by nomogram A. Table S13. Results of multivariate analysis within the high-risk group defined by nomogram A. Table S14. Results of multivariate analysis within the low-risk group defined by nomogram B. Table S15. Results of multivariate analysis within the high-risk group defined by nomogram B.
Supplementary Result from Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma
Authors: Peng Hao , Dong Di , Fang Meng-Jie , Li Lu , Tang Ling-Long , Chen Lei , Li Wen-Fei , Mao Yan-Ping , Fan Wei , Liu Li-Zhi , Tian Li , Lin Ai-Hua , Sun Ying , Tian Jie , Ma Jun
Published: April 2023

Supplementary Result
Supplementary Data from Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase III DECISION Trial
Authors: Brose Marcia S. , Schlumbeger Martin , Jeffers Michael , Kappeler Christian , Meinhardt Gerold , Peña Carol E.A.
Published: April 2023

Revised Supplemental materials
Supplementary Data from Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non–Small Cell Lung Cancer Patients
Authors: Lusk Christine M. , Watza Donovan , Dyson Greg , Craig Douglas , Ratliff Valerie , Wenzlaff Angela S. , Lonardo Fulvio , Bollig-Fischer Aliccia , Bepler Gerold , Purrington Kristen , Gadgeel Shirish , Schwartz Ann G.
Published: April 2023

Table S7
Supplementary Methods and Table from A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers
Authors: Kurzrock Razelle , Ball Douglas W. , Zahurak Marianna L. , Nelkin Barry D. , Subbiah Vivek , Ahmed Shabina , O'Connor Ashley , Karunsena Enusha , Parkinson Rose M. , Bishop Justin A. , Ha Yoonji , Sharma Rajni , Gocke Christopher D. , Zinner Ralph , Rudek Michelle A. , Sherman Steven I. , Azad Nilofer S.
Published: April 2023

Statistical futility analysis
Supplementary Tables S1, S2 from SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma
Authors: Isfort Ilka , Cyra Magdalene , Elges Sandra , Kailayangiri Sareetha , Altvater Bianca , Rossig Claudia , Steinestel Konrad , Grünewald Inga , Huss Sebastian , Eßeling Eva , Mikesch Jan-Henrik , Hafner Susanne , Simmet Thomas , Wozniak Agnieszka , Schöffski Patrick , Larsson Olle , Wardelmann Eva , Trautmann Marcel , Hartmann Wolfgang
Published: April 2023

Supplementary Table S1: Clinicopathological characteristics of synovial sarcoma tissue specimens (n=65) and semi-quantitative immunohistochemistry results Supplementary Table S2: Primer sequences
Supplementary Table 1 from Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy
Authors: Park Youngran , Chui M. Herman , Suryo Rahmanto Yohan , Yu Zheng-Cheng , Shamanna Raghavendra A. , Bellani Marina A. , Gaillard Stephanie , Ayhan Ayse , Viswanathan Akila , Seidman Michael M. , Franco Sonia , Leung Anthony K.L. , Bohr Vilhelm A. , Shih Ie-Ming , Wang Tian-Li
Published: April 2023

In vivo phosphoproteome
Supplementary Table S1 from Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
Authors: Laban Simon , Gangkofner Dominik S. , Holzinger Dana , Schroeder Lea , Eichmüller Stefan B. , Zörnig Inka , Jäger Dirk , Wichmann Gunnar , Dietz Andreas , Broglie Martina A. , Herold-Mende Christel C. , Dyckhoff Gerhard , Boscolo-Rizzo Paolo , Ezić Jasmin , Marienfeld Ralf , Möller Peter , Kraus Johann M. , Völkel Gunnar , Kestler Hans A. , Brunner Cornelia , Schuler Patrick J. , Wigand Marlene C. , Theodoraki Marie-Nicole , Doescher Johannes , Hoffmann Thomas K. , Pawlita Michael , Waterboer Tim , Butt Julia
Published: April 2023

Patient characteristics (non-oropharyngeal patients)
Supplementary Figures and Methods from Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy
Authors: Park Youngran , Chui M. Herman , Suryo Rahmanto Yohan , Yu Zheng-Cheng , Shamanna Raghavendra A. , Bellani Marina A. , Gaillard Stephanie , Ayhan Ayse , Viswanathan Akila , Seidman Michael M. , Franco Sonia , Leung Anthony K.L. , Bohr Vilhelm A. , Shih Ie-Ming , Wang Tian-Li
Published: April 2023

Supplementary Figures and Methods
Supplementary Figure S3 from Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
Authors: Laban Simon , Gangkofner Dominik S. , Holzinger Dana , Schroeder Lea , Eichmüller Stefan B. , Zörnig Inka , Jäger Dirk , Wichmann Gunnar , Dietz Andreas , Broglie Martina A. , Herold-Mende Christel C. , Dyckhoff Gerhard , Boscolo-Rizzo Paolo , Ezić Jasmin , Marienfeld Ralf , Möller Peter , Kraus Johann M. , Völkel Gunnar , Kestler Hans A. , Brunner Cornelia , Schuler Patrick J. , Wigand Marlene C. , Theodoraki Marie-Nicole , Doescher Johannes , Hoffmann Thomas K. , Pawlita Michael , Waterboer Tim , Butt Julia
Published: April 2023

Overall survival by HPV-status. Overall survival stratified by HPV-status based on A) molecular HPV-status, B) seropositivity to HPV-16 E6, C) seropositivity to any high-risk HPV-types and D) by molecular HPV-status if available and seropositivity to any high-risk HPV-types if molecular HPV-status was unavailable. Overall survival was significantly longer regardless of the definition of HPV-status (p<0.001 for all comparisons).
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Authors: Wang Rui , Gao Chan , Raymond Megan , Dito Gennaro , Kabbabe Dominic , Shao Xiao , Hilt Ed , Sun Yongliang , Pak Irene , Gutierrez Martin , Melero Ignacio , Spreafico Anna , Carvajal Richard D. , Ong Michael , Olszanski Anthony J. , Milburn Christina , Thudium Kent , Yang Zheng , Feng Yan , Fracasso Paula M. , Korman Alan J. , Aanur Praveen , Huang Shih-Min A. , Quigley Michael
Published: April 2023

Supplementary Figures and Tables
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Authors: Wang Rui , Gao Chan , Raymond Megan , Dito Gennaro , Kabbabe Dominic , Shao Xiao , Hilt Ed , Sun Yongliang , Pak Irene , Gutierrez Martin , Melero Ignacio , Spreafico Anna , Carvajal Richard D. , Ong Michael , Olszanski Anthony J. , Milburn Christina , Thudium Kent , Yang Zheng , Feng Yan , Fracasso Paula M. , Korman Alan J. , Aanur Praveen , Huang Shih-Min A. , Quigley Michael
Published: April 2023

Supplementary Figure 1
Supplementary Figure S1 from Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
Authors: Laban Simon , Gangkofner Dominik S. , Holzinger Dana , Schroeder Lea , Eichmüller Stefan B. , Zörnig Inka , Jäger Dirk , Wichmann Gunnar , Dietz Andreas , Broglie Martina A. , Herold-Mende Christel C. , Dyckhoff Gerhard , Boscolo-Rizzo Paolo , Ezić Jasmin , Marienfeld Ralf , Möller Peter , Kraus Johann M. , Völkel Gunnar , Kestler Hans A. , Brunner Cornelia , Schuler Patrick J. , Wigand Marlene C. , Theodoraki Marie-Nicole , Doescher Johannes , Hoffmann Thomas K. , Pawlita Michael , Waterboer Tim , Butt Julia
Published: April 2023

Consort diagram of the study cohort.
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Authors: Wang Rui , Gao Chan , Raymond Megan , Dito Gennaro , Kabbabe Dominic , Shao Xiao , Hilt Ed , Sun Yongliang , Pak Irene , Gutierrez Martin , Melero Ignacio , Spreafico Anna , Carvajal Richard D. , Ong Michael , Olszanski Anthony J. , Milburn Christina , Thudium Kent , Yang Zheng , Feng Yan , Fracasso Paula M. , Korman Alan J. , Aanur Praveen , Huang Shih-Min A. , Quigley Michael
Published: April 2023

Supplementary Figure 3
Supplementary Figure S2 from L-Carnitine–Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme
Authors: Fink Matthias A. , Paland Heiko , Herzog Susann , Grube Markus , Vogelgesang Silke , Weitmann Kerstin , Bialke Angela , Hoffmann Wolfgang , Rauch Bernhard H. , Schroeder Henry W.S. , Bien-Möller Sandra
Published: April 2023

Expression and survival analyses of CPT1A and CPT1C in GBM specimens
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Authors: Wang Rui , Gao Chan , Raymond Megan , Dito Gennaro , Kabbabe Dominic , Shao Xiao , Hilt Ed , Sun Yongliang , Pak Irene , Gutierrez Martin , Melero Ignacio , Spreafico Anna , Carvajal Richard D. , Ong Michael , Olszanski Anthony J. , Milburn Christina , Thudium Kent , Yang Zheng , Feng Yan , Fracasso Paula M. , Korman Alan J. , Aanur Praveen , Huang Shih-Min A. , Quigley Michael
Published: April 2023

Supplementary Figure 4
Supplementary Figure S1 from L-Carnitine–Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme
Authors: Fink Matthias A. , Paland Heiko , Herzog Susann , Grube Markus , Vogelgesang Silke , Weitmann Kerstin , Bialke Angela , Hoffmann Wolfgang , Rauch Bernhard H. , Schroeder Henry W.S. , Bien-Möller Sandra
Published: April 2023

Survival analysis of patients with primary GBM dependent on therapy and resection status
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Authors: Wang Rui , Gao Chan , Raymond Megan , Dito Gennaro , Kabbabe Dominic , Shao Xiao , Hilt Ed , Sun Yongliang , Pak Irene , Gutierrez Martin , Melero Ignacio , Spreafico Anna , Carvajal Richard D. , Ong Michael , Olszanski Anthony J. , Milburn Christina , Thudium Kent , Yang Zheng , Feng Yan , Fracasso Paula M. , Korman Alan J. , Aanur Praveen , Huang Shih-Min A. , Quigley Michael
Published: April 2023

Supplementary Figure 5C
Supplementary Data from An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Authors: Wang Rui , Gao Chan , Raymond Megan , Dito Gennaro , Kabbabe Dominic , Shao Xiao , Hilt Ed , Sun Yongliang , Pak Irene , Gutierrez Martin , Melero Ignacio , Spreafico Anna , Carvajal Richard D. , Ong Michael , Olszanski Anthony J. , Milburn Christina , Thudium Kent , Yang Zheng , Feng Yan , Fracasso Paula M. , Korman Alan J. , Aanur Praveen , Huang Shih-Min A. , Quigley Michael
Published: April 2023

Supplementary Figure 7
Supplementary Figures and Table from Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence
Authors: Ramakrishna Sneha , Highfill Steven L. , Walsh Zachary , Nguyen Sang M. , Lei Haiyan , Shern Jack F. , Qin Haiying , Kraft Ira L. , Stetler-Stevenson Maryalice , Yuan Constance M. , Hwang Jennifer D. , Feng Yang , Zhu Zhongyu , Dimitrov Dimiter , Shah Nirali N. , Fry Terry J.
Published: April 2023

Fig S1: Site density cell lines with cytokine analyses of normal healthy donors and patient-derived CD22 CART. Fig S2: Development and evaluation of high-affinity CD22V1 CAR. Fig S3: PKCB2 effects of Bryostatin1 and CD22 modulation with PKC-inhibitors. Fig S4: RNA-seq analysis of Bryostatin1 effects on KOPN8 and SEM Fig S5: Exhaustion markers in Bryostatin1 and CD19 CAR with Bryostatin1 Fig S6: Bioluminescence for Bryostatin1 in vivo experiments Table S1: Enrichment analysis of RNA-seq Bryostatin1-treated cells specific to intrinsic components of the plasma membrane
Supplemental legend from A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer
Authors: Iizuka Akira , Nonomura Chizu , Ashizawa Tadashi , Kondou Ryota , Ohshima Keiichi , Sugino Takashi , Mitsuya Koichi , Hayashi Nakamasa , Nakasu Yoko , Maruyama Kouji , Yamaguchi Ken , Akiyama Yasuto
Published: April 2023

Supplemental legend
Figure S8 from A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer
Authors: Iizuka Akira , Nonomura Chizu , Ashizawa Tadashi , Kondou Ryota , Ohshima Keiichi , Sugino Takashi , Mitsuya Koichi , Hayashi Nakamasa , Nakasu Yoko , Maruyama Kouji , Yamaguchi Ken , Akiyama Yasuto
Published: April 2023

PD-L1 and B7-H4 mRNA expression frequency in breast cancer subtype classified by the blue print gene signature
Supplementary Data from Interaction between Molecular Subtypes and Stromal Immune Infiltration before and after Treatment in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Authors: Hamy Anne-Sophie , Bonsang-Kitzis Hélène , De Croze Diane , Laas Enora , Darrigues Lauren , Topciu Lucian , Menet Emmanuelle , Vincent-Salomon Anne , Lerebours Florence , Pierga Jean-Yves , Brain Etienne , Feron Jean-Guillaume , Benchimol Gabriel , Lam Giang-Thanh , Laé Marick , Reyal Fabien
Published: April 2023

supplementary material
Supplementary Table 8 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Authors: Georgiadis Andrew , Durham Jennifer N. , Keefer Laurel A. , Bartlett Bjarne R. , Zielonka Magdalena , Murphy Derek , White James R. , Lu Steve , Verner Ellen L. , Ruan Finey , Riley David , Anders Robert A. , Gedvilaite Erika , Angiuoli Sam , Jones Siân , Velculescu Victor E. , Le Dung T. , Diaz Luis A. , Sausen Mark
Published: April 2023

Comparison of Tumor Mutation Burden and Microsatellite Status for Patients Evaluated for Response to Immune Checkpoint Blockade
Supplementary Table 6 from Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Authors: Georgiadis Andrew , Durham Jennifer N. , Keefer Laurel A. , Bartlett Bjarne R. , Zielonka Magdalena , Murphy Derek , White James R. , Lu Steve , Verner Ellen L. , Ruan Finey , Riley David , Anders Robert A. , Gedvilaite Erika , Angiuoli Sam , Jones Siân , Velculescu Victor E. , Le Dung T. , Diaz Luis A. , Sausen Mark
Published: April 2023

Comparison of Microsatellite Status Determined through Healthy Donor, Contrived, and Clinical Plasma Analyses